Sign InStart free
AwardedWorksEuropeanCompetitive dialogue

Removal of micropollutants and pharmaceuticals using membrane technology and post-treatment technique

Waterschap Vechtstromen · Competitive dialogue · 1 lots · 338733
Type
Works
45232420
Estimated value
€ 10M
estimated
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

Waterschap Vechtstromen has phased a contract through an EU procurement in the form of a competitive dialogue: a full-scale reference installation at the RWZI Enschede to remove micropollutants, particularly pharmaceutical residues, using membrane and post-treatment technology (ozone/UV/H₂O₂). The objective is to reduce concentrations in view of future RWZI effluent standards, reuse of treated wastewater, and knowledge sharing with other water boards.

Works · Competitive dialogue · European procedure

European
Contracting authority
Waterschap Vechtstromen
Contract type
Works
Competitive dialogue
Estimated value
€10,000,000
estimated value
Submission deadline
Ongoing
10:00
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
45232420
Location
Netherlands
CharacteristicsCPV 45WorksEU tender

01What is being requested

Waterschap Vechtstromen has phased a contract through an EU procurement in the form of a competitive dialogue: a full-scale reference installation at the RWZI Enschede to remove micropollutants, particularly pharmaceutical residues, using membrane and post-treatment technology (ozone/UV/H₂O₂). The objective is to reduce concentrations in view of future RWZI effluent standards, reuse of treated wastewater, and knowledge sharing with other water boards.

Waterschap Vechtstromen intends to tender the contract ‘Removal of micropollutants and pharmaceuticals using membrane technology and post-treatment technique’ by means of an EU procurement in the form of a competitive dialogue. [newline][newline]The objective of this project is to reduce the concentration of organic micropollutants, specifically pharmaceutical residues, in the treated wastewater of the RWZI Enschede. This serves as a precursor to future requirements for pharmaceutical residues in RWZI effluent and, additionally, brings the reuse of treated wastewater for industrial or other p

45232420€ 10MWorks
1Removal of micropollutants and pharmaceuticals using membrane technology and post-treatment technique€10,000,000

02Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

03Value in context

€10,000,000

04Bidders in this segment

#Likely bidderFitWins
1Heijmans Infra B.V.SME9865×
2Dura Vermeer Infra Regionale Projecten BVSME9858×
3Vandervalk+degroot B.V.SME9658×
4REMONDIS Smart Infra B.V.SME9628×
5Van Oord Nederland BVSME9319×
6De Jong Zuurmond Infrabeheer, Onderhoud & Services B.V.SME8926×

05Legal themes that may be relevant here

06Frequently asked questions

What is the objective of the installation at the RWZI Enschede?
The objective is to reduce the concentration of organic micropollutants, specifically pharmaceutical residues, in the treated wastewater of the RWZI Enschede.
Which technologies are being tested in this project?
A full-scale reference installation is being carried out in which a combination of membrane technology with an ozone or UV/H2O2 treatment is tested in practice.
Why is this technology being applied?
The application serves to prepare for future requirements for pharmaceutical residues in RWZI effluent and to enable the reuse of treated wastewater for industrial or other purposes.
What is the intended societal value of the knowledge gained?
The knowledge gained from the full-scale practical test is intended to support other water boards in their search for the efficient removal of organic micropollutants.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 1,4 mln
median
€ 3,6 mln
p75
€ 9,1 mln
€ 10 mln

Gegunde waarden in CPV 45 · werken n=3159